Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Viral Load"" wg kryterium: Temat


Tytuł:
Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination.
Autorzy:
Duran-Castells C; IrsiCaixa AIDS Research Institute Badalona, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Universitat Autònoma de Barcelona, Spain.
Prats A; Fight Infections Foundation and Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Oriol-Tordera B; IrsiCaixa AIDS Research Institute Badalona, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Universitat Autònoma de Barcelona, Spain.
Llano A; IrsiCaixa AIDS Research Institute Badalona, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Galvez C; IrsiCaixa AIDS Research Institute Badalona, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Martinez-Picado J; IrsiCaixa AIDS Research Institute Badalona, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain; Catalan Institution for Research Advanced Studies (ICREA), Barcelona, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.
Ballana E; IrsiCaixa AIDS Research Institute Badalona, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Garcia-Vidal E; IrsiCaixa AIDS Research Institute Badalona, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Clotet B; IrsiCaixa AIDS Research Institute Badalona, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Fight Infections Foundation and Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.
Muñoz-Moreno JA; Fight Infections Foundation and Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Faculty of Psychology and Education Sciences, Universitat Oberta de Catalunya (UOC), Barcelona, Spain.
Hanke T; The Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK; Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
Moltó J; Fight Infections Foundation and Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.
Mothe B; IrsiCaixa AIDS Research Institute Badalona, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Fight Infections Foundation and Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.
Brander C; IrsiCaixa AIDS Research Institute Badalona, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Universitat Autònoma de Barcelona, Spain; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain; Catalan Institution for Research Advanced Studies (ICREA), Barcelona, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.
Ruiz-Riol M; IrsiCaixa AIDS Research Institute Badalona, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain. Electronic address: .
Pokaż więcej
Źródło:
EBioMedicine [EBioMedicine] 2023 Sep; Vol. 95, pp. 104732. Date of Electronic Publication: 2023 Jul 26.
Typ publikacji:
Clinical Trial, Phase I; Journal Article
MeSH Terms:
HIV Infections*/blood
HIV Infections*/drug therapy
HIV Infections*/genetics
HIV Infections*/immunology
HIV-1*/genetics
HIV-1*/physiology
Viral Load*/drug effects
Viral Load*/genetics
Viral Load*/immunology
Biomarkers*/blood
Biomarkers*/metabolism
Humans ; CD4-Positive T-Lymphocytes ; HIV Seropositivity ; Leukocytes, Mononuclear ; Proteome ; Proteomics ; Sialic Acid Binding Ig-like Lectin 3/blood ; Sialic Acid Binding Ig-like Lectin 3/genetics ; Sialic Acid Binding Ig-like Lectin 3/immunology ; Vaccination ; Anti-HIV Agents
Czasopismo naukowe
Tytuł:
Africa-specific human genetic variation near CHD1L associates with HIV-1 load.
Autorzy:
McLaren PJ; Sexually Transmitted and Blood-Borne Infections Division at JC Wilt Infectious Diseases Research Centre, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, Manitoba, Canada. .; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada. .
Porreca I; Wellcome Trust Sanger Institute, Hinxton, UK.
Iaconis G; Department of Medicine, University of Cambridge, Cambridge, UK.
Mok HP; Department of Medicine, University of Cambridge, Cambridge, UK.
Mukhopadhyay S; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Karakoc E; Wellcome Trust Sanger Institute, Hinxton, UK.
Cristinelli S; Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Pomilla C; Wellcome Trust Sanger Institute, Hinxton, UK.
Bartha I; Global Health Institute, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Thorball CW; Global Health Institute, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland.; Precision Medicine Unit, Biomedical Data Science Center, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.
Tough RH; Sexually Transmitted and Blood-Borne Infections Division at JC Wilt Infectious Diseases Research Centre, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.
Angelino P; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Kiar CS; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Carstensen T; Wellcome Trust Sanger Institute, Hinxton, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.
Fatumo S; The African Computational Genomics (TACG) Research Group, MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.; Department of Non-Communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Porter T; Wellcome Trust Sanger Institute, Hinxton, UK.
Jarvis I; Department of Medicine, University of Cambridge, Cambridge, UK.
Skarnes WC; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Bassett A; Wellcome Trust Sanger Institute, Hinxton, UK.
DeGorter MK; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Sathya Moorthy MP; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
Tuff JF; Sexually Transmitted and Blood-Borne Infections Division at JC Wilt Infectious Diseases Research Centre, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Kim EY; Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Walter M; Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Simons LM; Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Bashirova A; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA.; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Buchbinder S; Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA.
Carrington M; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA.; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Ragon Institute of MGH, MIT and Harvard, Boston, MA, USA.
Cossarizza A; Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.
De Luca A; University Division of Infectious Diseases, Siena University Hospital, Siena, Italy.; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Goedert JJ; Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Goldstein DB; Institute for Genomic Medicine, Columbia University, New York, NY, USA.
Haas DW; Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
Herbeck JT; Department of Global Health, University of Washington, Seattle, WA, USA.
Johnson EO; GenOmics and Translational Research Center and Fellow Program, RTI International, Research Triangle Park, NC, USA.
Kaleebu P; Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda.; London School of Hygiene and Tropical Medicine, London, UK.
Kilembe W; Center for Family Health Research-Zambia, Lusaka, Zambia.
Kirk GD; Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA.
Kootstra NA; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Kral AH; Community Health Research Division, RTI International, Berkeley, CA, USA.
Lambotte O; Université Paris Saclay, Inserm UMR1184, CEA, Le Kremlin-Bicêtre, France.; APHP, Department of Clinical Immunology, Bicêtre Hospital, Le Kremlin-Bicêtre, France.
Luo M; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.; Vaccine and Therapeutics Laboratory, Medical and Scientific Affairs, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Mallal S; Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Institute for Immunology & Infectious Diseases, Murdoch University, Perth, Western Australia, Australia.
Martinez-Picado J; University of Vic-Central University of Catalonia, Vic, Spain.; IrsiCaixa AIDS Research Institute, Badalona, Spain.; Catalan Institution for Research and Advanced Studies, Barcelona, Spain.; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.
Meyer L; INSERM U1018, Université Paris-Saclay, Le Kremlin Bicêtre, France.; AP-HP, Hôpital de Bicêtre, Département d'Épidémiologie, Le Kremlin Bicêtre, France.
Miro JM; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.; Infectious Diseases Service, Hospital Clinic-Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Moodley P; National Health Laboratory Service, South Africa and University of KwaZulu-Natal, Durban, South Africa.
Motala AA; Department of Diabetes and Endocrinology, School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa.
Mullins JI; Department of Microbiology, University of Washington, Seattle, WA, USA.
Nam K; Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Obel N; Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Pirie F; Department of Diabetes and Endocrinology, School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa.
Plummer FA; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.
Poli G; Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.; School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Price MA; International AIDS Vaccine Initiative, New York, NY, USA.; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
Rauch A; Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Theodorou I; Laboratoire d'Immunologie, Hôpital Robert Debré Paris, Paris, France.
Trkola A; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Walker BD; Ragon Institute of MGH, MIT and Harvard, Boston, MA, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA.
Winkler CA; Basic Research Laboratory, Molecular Genetic Epidemiology Section, Frederick National Laboratory for Cancer Research and Cancer Innovative Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Zagury JF; Laboratoire Génomique, Bioinformatique et Chimie Moléculaire, EA7528, Conservatoire National des Arts et Métiers, HESAM Université, Paris, France.
Montgomery SB; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
Ciuffi A; Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Hultquist JF; Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Wolinsky SM; Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Dougan G; Wellcome Trust Sanger Institute, Hinxton, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.
Lever AML; Department of Medicine, University of Cambridge, Cambridge, UK.; Department of Medicine, National University of Singapore, Singapore, Singapore.
Gurdasani D; Queen Mary University of London, London, UK.; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
Groom H; Department of Medicine, University of Cambridge, Cambridge, UK.
Sandhu MS; Department of Epidemiology & Biostatistics, School of Public Health, Imperial College London, London, UK. .; MRC Centre for Environment and Health, School of Public Health, Imperial College London, London, UK. .; Omnigen Biodata, Cambridge, UK. .
Fellay J; Global Health Institute, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland. .; Swiss Institute of Bioinformatics, Lausanne, Switzerland. .; Precision Medicine Unit, Biomedical Data Science Center, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland. .
Pokaż więcej
Źródło:
Nature [Nature] 2023 Aug; Vol. 620 (7976), pp. 1025-1030. Date of Electronic Publication: 2023 Aug 02.
Typ publikacji:
Journal Article
MeSH Terms:
DNA Helicases*/genetics
DNA Helicases*/metabolism
DNA-Binding Proteins*/genetics
DNA-Binding Proteins*/metabolism
Genetic Variation*
HIV Infections*/genetics
HIV-1*/growth & development
HIV-1*/physiology
Viral Load*/genetics
Humans ; Cell Line ; Africa ; Chromosomes, Human, Pair 1/genetics ; Alleles ; RNA, Long Noncoding/genetics ; Virus Replication
Czasopismo naukowe
Tytuł:
Barriers and facilitators to viral load suppression among people living with HIV following intensive adherence counseling in Kampala, Uganda: A qualitative study.
Autorzy:
Izudi J; Infectious Diseases Institute, College of Health Sciences, Makerere University, Uganda; University of California Global Health Institute (UCGHI), University of California San Francisco, San Francisco, CA, USA. Electronic address: .
Cattamanchi A; Division of Pulmonary Diseases and Critical Care Medicine, University of California Irvine, Irvine, CA, USA.
Castelnuovo B; Infectious Diseases Institute, College of Health Sciences, Makerere University, Uganda.
King R; Institute for Global Health Sciences, Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
Pokaż więcej
Źródło:
Social science & medicine (1982) [Soc Sci Med] 2024 Feb; Vol. 343, pp. 116595. Date of Electronic Publication: 2024 Jan 14.
Typ publikacji:
Journal Article
MeSH Terms:
HIV*
HIV Infections*/drug therapy
HIV Infections*/psychology
Adult ; Adolescent ; Humans ; Uganda ; Viral Load ; Counseling ; Medication Adherence/psychology
Czasopismo naukowe
Tytuł:
Effectiveness of intensive adherence counselling in achieving an undetectable viral load among people on antiretroviral therapy with low-level viraemia in Uganda.
Autorzy:
Nanyeenya N; Department of Epidemiology and Biostatistics, School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda.; Ministry of Health Central Public Health Laboratories, Kampala, Uganda.
Nakanjako D; Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Makumbi F; Department of Epidemiology and Biostatistics, School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda.
Nakigozi G; Rakai Health Sciences Project, Rakai, Uganda.
Nalugoda F; Rakai Health Sciences Project, Rakai, Uganda.
Kigozi G; Rakai Health Sciences Project, Rakai, Uganda.
Nasuuna E; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
Kibira SPS; Department of Community Health and Behavioral Sciences, School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda.
Nabadda S; Ministry of Health Central Public Health Laboratories, Kampala, Uganda.
Kiyaga C; Ministry of Health Central Public Health Laboratories, Kampala, Uganda.
Huzaifah M; Department of Epidemiology and Biostatistics, School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda.
Kiwanuka N; Department of Epidemiology and Biostatistics, School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda.
Pokaż więcej
Źródło:
HIV medicine [HIV Med] 2024 Feb; Vol. 25 (2), pp. 245-253. Date of Electronic Publication: 2023 Oct 18.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
Adult ; Humans ; Counseling ; Uganda ; Viral Load ; Viremia/drug therapy
Czasopismo naukowe
Tytuł:
Context-dependent accuracy of the cobas plasma separation card for HCV RNA viral load measurement.
Autorzy:
Qureshi H; Doctor's Plaza, Clifton, Karachi, Pakistan.
Duran AC; Roche Diagnostics International AG, Rotkreuz, Switzerland.
Mahmood H; Planning, Development and Monitoring Unit, Ministry of Health, Islamabad, Pakistan.
Sarwar Z; Hepatitis Elimination, Punjab, Lahore, Pakistan.
Mahmood K; Hepatitis & Infection Control Program, Punjab, Lahore, Pakistan.
Midde K; Roche Molecular Systems, Inc., Pleasanton, California, USA.
Canchola JA; Roche Molecular Systems, Inc., Pleasanton, California, USA.
Parkin NT; Data First Consulting, Sebastopol, California, USA.
La Brot B; Roche Molecular Systems, Inc., Pleasanton, California, USA.
Pokaż więcej
Źródło:
Journal of viral hepatitis [J Viral Hepat] 2024 Mar; Vol. 31 (3), pp. 156-160. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
RNA, Viral*
Hepatitis C*/diagnosis
Humans ; Viral Load/methods ; Hepacivirus/genetics ; Plasma ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
Compliance to Viral Load Monitoring Schedules Among Women Attending Prevention of Vertical HIV Transmission Services Before and During the COVID-19 Pandemic in Ehlanzeni District, Mpumalanga, South Africa.
Autorzy:
Mbira TE; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa.; Division of Epidemiology and Biostatistics, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
Kufa T; Division of Epidemiology and Biostatistics, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.; Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa.
Sherman GG; Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa.; Department of Paediatrics and Child Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Ngandu NK; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa. .
Pokaż więcej
Corporate Authors:
PHANGISA Study Team
Źródło:
AIDS and behavior [AIDS Behav] 2024 Mar; Vol. 28 (3), pp. 868-885. Date of Electronic Publication: 2023 Oct 13.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/epidemiology
HIV Infections*/prevention & control
HIV Infections*/drug therapy
COVID-19*/epidemiology
COVID-19*/prevention & control
Anti-HIV Agents*/therapeutic use
Humans ; Female ; Adult ; Pandemics/prevention & control ; Viral Load ; South Africa/epidemiology
Czasopismo naukowe
Tytuł:
Clinical characteristics and outcomes of Epstein-Barr virus viral load after allogeneic hematopoietic stem cell transplantation.
Autorzy:
Tsushima T; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan. .
Masuda SI; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Yoda N; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Kainuma S; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Kimeda C; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Konno S; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Tanaka K; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Matsuo K; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Shimoji S; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Kimura K; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Arai H; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Utsu Y; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Imadome KI; Department of Advanced Medicine for Virus Infections, National Center for Child Health and Development (NCCHD), Tokyo, Japan.
Aotsuka N; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, 90-1 Iida-Cho, Narita, 286-0041, Japan.
Pokaż więcej
Źródło:
Annals of hematology [Ann Hematol] 2024 Mar; Vol. 103 (3), pp. 935-946. Date of Electronic Publication: 2023 Dec 29.
Typ publikacji:
Journal Article
MeSH Terms:
Epstein-Barr Virus Infections*/drug therapy
Hematopoietic Stem Cell Transplantation*/adverse effects
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Graft vs Host Disease*/drug therapy
Lymphoproliferative Disorders*/etiology
Humans ; Herpesvirus 4, Human/physiology ; Retrospective Studies ; Viral Load ; Immunosuppressive Agents/therapeutic use ; DNA, Viral
Czasopismo naukowe
Tytuł:
HIV disease metrics and COVID-19 infection severity and outcomes in people living with HIV in central and eastern Europe.
Autorzy:
Oprea C; Victor Babes Clinical Hospital for Infectious and Tropical Diseases, Bucharest, Romania.; Carol Davila University for Medicine and Pharmacy, Bucharest, Romania.
Quirke S; Department of Medicine, Galway University Hospital, Galway, Ireland.
Ianache I; Victor Babes Clinical Hospital for Infectious and Tropical Diseases, Bucharest, Romania.; Carol Davila University for Medicine and Pharmacy, Bucharest, Romania.
Bursa D; Department of Adults' Infectious Diseases, Medical University of Warsaw, Warsaw, Poland.
Antoniak S; Viral Hepatitis and AIDS Department, Gromashevsky Institute of Epidemiology and Infectious Diseases, Kyiv, Ukraine.
Bogdanic N; University Hospital for Infectious Diseases, University of Zagreb, School of Medicine, Zagreb, Croatia.
Vassilenko AI; Global Fund Grant Management Department, Republican Scientific and Practical Center for Medical Technologies, Minsk, Belarus.
Aimla K; Tartu University Hospital, Tartu, Estonia.
Matulionyte R; Vilnius University, Faculty of Medicine, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
Rukhadze N; Infectious Diseases, AIDS and Clinical Immunology Center, Tbilisi, Georgia.
Harxhi A; University Hospital Center of Tirana, Infectious Disease Service, Tirana, Albania.
Fleischhans L; Department of Infectious Diseases, 1st Faculty of Medicine, Charles University in Prague and Faculty Hospital Bulovka Hospital, Prague, Czech Republic.
Lakatos B; National Institute of Hematology and Infectious Diseases, South-Pest Central Hospital, National Center of HIV, Budapest, Hungary.
Sedlacek D; Charles University, Faculty of Medicine in Plzeň, University Hospital Plzeň, Plzen, Czech Republic.
Dragovic G; Faculty of Medicine, University of Belgrade, Department of Pharmacology, Clinical Pharmacology and Toxicology, Belgrade, Serbia.
Verhaz A; Department for Infectious Diseases, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina.
Yancheva N; Department for AIDS, Specialized Hospital for Active Treatment of Infectious and Parasitic Disease Sofia, Sofi, Bulgaria.
Acet O; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, Izmir, Turkey.
Protopapas K; University General Hospital Attikon, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Kowalska JD; Department of Adults' Infectious Diseases, Medical University of Warsaw, Warsaw, Poland.
Pokaż więcej
Corporate Authors:
Euroguidelines in Central and Eastern Europe Network Group
Źródło:
HIV medicine [HIV Med] 2024 Mar; Vol. 25 (3), pp. 343-352. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
COVID-19*/epidemiology
COVID-19*/complications
Respiratory Insufficiency*
Humans ; Male ; Female ; Retrospective Studies ; COVID-19 Testing ; SARS-CoV-2 ; CD4 Lymphocyte Count ; Europe, Eastern ; Viral Load
Czasopismo naukowe
Tytuł:
Association between Human Papillomavirus 16 Viral Load in Pregnancy and Preterm Birth.
Autorzy:
Khayargoli P; Department of Social and Preventive Medicine, Université de Montréal, Montreal, QC H3N 1X9, Canada.; Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, QC H3T 1C5, Canada.
Mayrand MH; Department of Social and Preventive Medicine, Université de Montréal, Montreal, QC H3N 1X9, Canada.; Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, QC H2X 0A9, Canada.; Department of Obstetrics and Gynecology, Université de Montréal, Montreal, QC H3C 3J7, Canada.
Niyibizi J; Department of Social and Preventive Medicine, Université de Montréal, Montreal, QC H3N 1X9, Canada.; Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, QC H3T 1C5, Canada.
Audibert F; Department of Obstetrics and Gynecology, Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, QC H3T 1C5, Canada.
Laporte L; Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, QC H3T 1C5, Canada.
Lacaille J; Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, QC H2X 0A9, Canada.
Carceller AM; Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, QC H3T 1C5, Canada.
Lacroix J; Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, QC H3T 1C5, Canada.
Comète É; Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, QC H2X 0A9, Canada.
Coutlée F; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC H3T 1J4, Canada.
Trottier H; Department of Social and Preventive Medicine, Université de Montréal, Montreal, QC H3N 1X9, Canada.; Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, QC H3T 1C5, Canada.
Pokaż więcej
Corporate Authors:
HERITAGE Study Group
Źródło:
Viruses [Viruses] 2024 Feb 15; Vol. 16 (2). Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Journal Article
MeSH Terms:
Premature Birth*
Papillomavirus Infections*
Infant, Newborn ; Female ; Humans ; Pregnancy ; Human papillomavirus 16/genetics ; Viral Load ; Real-Time Polymerase Chain Reaction ; DNA, Viral/genetics
Czasopismo naukowe
Tytuł:
Evaluation of two automated real-time PCR-based quantification methods for whole blood Epstein-Barr viral load.
Autorzy:
Vancutsem E; Laboratory of Microbiology and infection control, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium. Electronic address: .
Crombé F; Laboratory of Microbiology and infection control, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
Soetens O; Laboratory of Microbiology and infection control, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
Wautier M; Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB), Université Libre de Bruxelles (ULB), Brussels, Belgium.
Dördelmann C; Altona Diagnostics, Hamburg, Germany.
Piérard D; Laboratory of Microbiology and infection control, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
Wybo I; Laboratory of Microbiology and infection control, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
Demuyser T; Laboratory of Microbiology and infection control, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
Pokaż więcej
Źródło:
Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2024 Feb; Vol. 108 (2), pp. 116101. Date of Electronic Publication: 2023 Oct 08.
Typ publikacji:
Journal Article
MeSH Terms:
Herpesvirus 4, Human*/genetics
Epstein-Barr Virus Infections*/diagnosis
Humans ; Real-Time Polymerase Chain Reaction ; Viral Load/methods ; DNA, Viral/genetics
Czasopismo naukowe
Tytuł:
m-PIMA™ HIV1/2 VL: A suitable tool for HIV-1 and HIV-2 viral load quantification in West Africa.
Autorzy:
Diop-Ndiaye H; Cheikh Anta Diop University and Bacteriology-Virology UTH Aristide le Dantec, Dakar, Senegal. Electronic address: .
Sène PY; Bacteriology-Virology UTH Aristide le Dantec, Dakar, Senegal.
Coulibaly K; Division de Lutte contre le SIDA/IST, Dakar, Senegal.
Diallo M; Clinton Health Access Initiative, Dakar, Senegal.
Diallo S; Bacteriology-Virology UTH Aristide le Dantec, Dakar, Senegal.
Diop K; Division de Lutte contre le SIDA/IST, Dakar, Senegal.
Sow-Ndoye A; Institut de Recherche en Santé, de surveillance épidémiologique et de Formation, Dakar, Senegal.
Fall M; Bacteriology-Virology UTH Aristide le Dantec, Dakar, Senegal.
Ndiaye AJS; Institut de Recherche en Santé, de surveillance épidémiologique et de Formation, Dakar, Senegal.
Mathebula E; School of Health Systems and Public Health, Faculty of Health Science, University of Pretoria, Pretoria, South Africa.
Ba AA; Bacteriology-Virology UTH Aristide le Dantec, Dakar, Senegal.
Lejeune C; Clinton Health Access Initiative, Dakar, Senegal.
Manga NMP; Bacteriology-Virology UTH Aristide le Dantec, Dakar, Senegal.
Camara M; Cheikh Anta Diop University and Bacteriology-Virology UTH Aristide le Dantec, Dakar, Senegal.
Ndour CT; Division de Lutte contre le SIDA/IST, Dakar, Senegal.
Kane CT; Institut de Recherche en Santé, de surveillance épidémiologique et de Formation, Dakar, Senegal.
Pokaż więcej
Źródło:
Journal of virological methods [J Virol Methods] 2024 Feb; Vol. 324, pp. 114872. Date of Electronic Publication: 2023 Dec 19.
Typ publikacji:
Journal Article
MeSH Terms:
HIV-1*/genetics
HIV Infections*/diagnosis
Humans ; HIV-2/genetics ; Viral Load/methods ; Sensitivity and Specificity ; Africa, Western ; RNA, Viral/genetics
Czasopismo naukowe
Tytuł:
Viral load kinetics and the clinical consequences of cytomegalovirus in kidney transplantation.
Autorzy:
Dobrer S; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Sherwood KR; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Hirji I; Global Evidence and Outcomes, Takeda Development Center Americas, Inc., Lexington, MA, United States.
Lan J; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.; Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Gill J; Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Matic N; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Keown PA; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.; Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Jan 31; Vol. 14, pp. 1302627. Date of Electronic Publication: 2024 Jan 31 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Kidney Transplantation*/adverse effects
Cytomegalovirus Infections*
Humans ; Cytomegalovirus/genetics ; Viral Load ; Viremia/drug therapy
Czasopismo naukowe
Tytuł:
Clinical Significance of Elevated KSHV Viral Load in HIV-Related Kaposi's Sarcoma Patients in South Africa.
Autorzy:
Tibenderana RM; Department of Radiation Oncology, University of Cape Town, Cape Town 7925, South Africa.
Blumenthal MJ; Department of Integrative Biomedical Sciences, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa.; International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town 7925, South Africa.
Bukajumbe E; Aberdeen Surgery, Aberdeen, NSW 2336, Australia.; Hatchile Consult Ltd., Kampala 759125, Uganda.
Schäfer G; Department of Integrative Biomedical Sciences, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa.; International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town 7925, South Africa.
Mohamed Z; Department of Radiation Oncology, University of Cape Town, Cape Town 7925, South Africa.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Jan 26; Vol. 16 (2). Date of Electronic Publication: 2024 Jan 26.
Typ publikacji:
Journal Article
MeSH Terms:
Sarcoma, Kaposi*
Herpesvirus 8, Human*/genetics
HIV Infections*
Adult ; Humans ; South Africa/epidemiology ; Retrospective Studies ; Viral Load ; Clinical Relevance
Czasopismo naukowe
Tytuł:
Internationally standardized respiratory viral load testing with limited resources: A derivative-of-care calibration strategy for SARS-CoV-2.
Autorzy:
Tao L; Department of Pathology, Microbiology, and Immunology Vanderbilt University Medical Center Nashville Tennessee USA.
Chan A; Department of Pathology, Microbiology, and Immunology Vanderbilt University Medical Center Nashville Tennessee USA.
Maris A; Department of Pathology, Microbiology, and Immunology Vanderbilt University Medical Center Nashville Tennessee USA.
Schmitz JE; Department of Pathology, Microbiology, and Immunology Vanderbilt University Medical Center Nashville Tennessee USA.; Department of Urology Vanderbilt University Medical Center Nashville Tennessee USA.; Vanderbilt Institute for Infection, Immunology, and Inflammation Vanderbilt University Medical Center Nashville Tennessee USA.
Pokaż więcej
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Jan 23; Vol. 18 (1), pp. e13207. Date of Electronic Publication: 2024 Jan 23 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/diagnosis
Humans ; COVID-19 Testing ; Calibration ; SARS-CoV-2/genetics ; Viral Load
Czasopismo naukowe
Tytuł:
Comparison of influenza viral load in nasopharyngeal and midturbinate swabs.
Autorzy:
Bernasconi C; F. Hoffmann-La Roche Ltd. Basel Switzerland.; Present address: Limites Medical Research Ltd. Vacallo Switzerland.
Katugampola L; Roche Products Ltd. Welwyn Garden City UK.
Wildum S; F. Hoffmann-La Roche Ltd. Basel Switzerland.
Pokaż więcej
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Jan 21; Vol. 18 (1), pp. e13253. Date of Electronic Publication: 2024 Jan 21 (Print Publication: 2024).
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article
MeSH Terms:
Influenza, Human*/diagnosis
Humans ; Viral Load ; Serologic Tests ; Nasopharynx
Czasopismo naukowe
Tytuł:
Incidence of low-level viremia and its impact on virologic failure among people living with HIV who started an integrase strand transfer inhibitors: a longitudinal cohort study.
Autorzy:
Lao X; Department of Infectious Disease, Beijing Ditan Hospital Capital Medical University, Beijing, 100015, China.
Zhang H; WHO Collaborating Centre for Comprehensive Management of HIV Treatment and Care, Beijing Ditan Hospital Capital Medical University, Beijing, 100015, China.
Deng M; Clinical Center for HIV/AIDS, Beijing Ditan Hospital Capital Medical University, Beijing, 100015, China.
Li Q; Department of Infectious Disease, Beijing Ditan Hospital Capital Medical University, Beijing, 100015, China.
Xiao Q; Department of Infectious Disease, Beijing Ditan Hospital Capital Medical University, Beijing, 100015, China.
He L; State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
Ma L; State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
Song A; Department of Gastroenterology, Beijing Ditan Hospital Capital Medical University, Beijing, 100015, China.
Liang X; Department of Infectious Disease, Beijing Ditan Hospital Capital Medical University, Beijing, 100015, China.
Yu F; Department of Infectious Disease, Beijing Ditan Hospital Capital Medical University, Beijing, 100015, China.
Zhao H; Clinical Center for HIV/AIDS, Beijing Ditan Hospital Capital Medical University, Beijing, 100015, China.
Zhang F; Department of Infectious Disease, Beijing Ditan Hospital Capital Medical University, Beijing, 100015, China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Jan 02; Vol. 24 (1), pp. 8. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/drug therapy
Anti-HIV Agents*/therapeutic use
Anti-HIV Agents*/pharmacology
Humans ; Longitudinal Studies ; Incidence ; Viremia/drug therapy ; Treatment Failure ; Cohort Studies ; Viral Load ; Integrase Inhibitors ; Integrases/pharmacology ; Integrases/therapeutic use
Czasopismo naukowe
Tytuł:
A Retrospective Study on COVID-19 Infections Caused by Omicron Variant with Clinical, Epidemiological, and Viral Load Evaluations in Breakthrough Infections.
Autorzy:
Liu J; Department of Medical Imaging, Guizhou Provincial People Hospital, Guiyang City, Guizhou Province, 550000, China.; Department of Radiology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
Wen R; Department of Medical Imaging, Guizhou Provincial People Hospital, Guiyang City, Guizhou Province, 550000, China.; Department of Radiology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, China.; Medical College, Guizhou University, Guizhou,550000, China.
Wang N; Department of Medical Imaging, Guizhou Provincial People Hospital, Guiyang City, Guizhou Province, 550000, China.
Li G; College of Mathematics and Statistics, Chongqing University, Chongqing, 400044, China.
Xu P; Department of Radiology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
Li X; Department of Radiology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
Zeng X; Department of Medical Imaging, Guizhou Provincial People Hospital, Guiyang City, Guizhou Province, 550000, China.
Liu C; Department of Radiology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
Pokaż więcej
Źródło:
International journal of medical sciences [Int J Med Sci] 2024 Jan 01; Vol. 21 (3), pp. 454-463. Date of Electronic Publication: 2024 Jan 01 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Breakthrough Infections*
COVID-19*/epidemiology
Aged ; Male ; Humans ; Female ; Adolescent ; Young Adult ; Adult ; Middle Aged ; Retrospective Studies ; China/epidemiology ; SARS-CoV-2 ; Viral Load
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Challenges and Pragmatic Solutions for Assessing the Reliability of HIV-1 Viral Load Monitoring in Resource-Constrained Settings.
Autorzy:
Demosthenes JP; Department of Clinical Virology, Christian Medical College, Vellore, India, .
Ghale BC; Department of Clinical Virology, Christian Medical College, Vellore, India.
Alex D; Department of Clinical Virology, Christian Medical College, Vellore, India.
Ramalingam VV; Department of Clinical Virology, Christian Medical College, Vellore, India.
Fletcher GJ; Department of Clinical Virology, Christian Medical College, Vellore, India.
Abraham P; Department of Clinical Virology, Christian Medical College, Vellore, India.
Kannangai R; Department of Clinical Virology, Christian Medical College, Vellore, India.
Pokaż więcej
Źródło:
Intervirology [Intervirology] 2024; Vol. 67 (1), pp. 1-5. Date of Electronic Publication: 2023 Nov 26.
Typ publikacji:
Wiadomości
MeSH Terms:
HIV-1*/genetics
HIV Infections*/diagnosis
Humans ; Reproducibility of Results ; Viral Load/methods ; RNA, Viral/genetics ; Sensitivity and Specificity
Periodyk
Tytuł:
Examining Concordance Between Self-Report and Biomedical HIV Viral Load Data: A Scoping Review.
Autorzy:
Dorshimer M; Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, NY, USA.
Hirshfield S; Department of Medicine, STAR Program, SUNY Downstate Health Sciences University, 450 Clarkson Avenue, MSC 1240, Brooklyn, NY, 11203-2012, USA. .
Mayer J; College of Medicine, SUNY Downstate Health Sciences University, Brooklyn, United States, 11203, New York.
Aidala AA; Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, NY, USA.
Pokaż więcej
Źródło:
AIDS and behavior [AIDS Behav] 2024 Jan; Vol. 28 (1), pp. 93-104. Date of Electronic Publication: 2023 Jul 26.
Typ publikacji:
Journal Article; Review
MeSH Terms:
HIV Infections*/diagnosis
HIV Infections*/epidemiology
Humans ; Self Report ; Viral Load ; HIV Testing ; Research Design
Czasopismo naukowe
Tytuł:
Pre-Infection Innate Immunity Attenuates SARS-CoV-2 Infection and Viral Load in iPSC-Derived Alveolar Epithelial Type 2 Cells.
Autorzy:
Kumar, Satish (AUTHOR)
Granados, Jose (AUTHOR)
Aceves, Miriam (AUTHOR)
Peralta, Juan (AUTHOR)
Leandro, Ana C. (AUTHOR)
Thomas, John (AUTHOR)
Williams-Blangero, Sarah (AUTHOR)
Curran, Joanne E. (AUTHOR)
Blangero, John (AUTHOR)
Pokaż więcej
Źródło:
Cells (2073-4409). Mar2024, Vol. 13 Issue 5, p369. 19p.
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies